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Abstract
Background: Gene fusions derive from chromosomal rearrangements and the resulting chimeric transcripts are often endowed
with oncogenic potential. Furthermore, they serve as diagnostic tools for the clinical classification of cancer subgroups with
different prognosis and, in some cases, they can provide specific drug targets. So far, many efforts have been carried out to study
gene fusion events occurring in tumor samples. In recent years, the availability of a comprehensive Next Generation Sequencing
dataset for all the existing human tumor cell lines has provided the opportunity to further investigate these data in order to
identify novel and still uncharacterized gene fusion events.
Results: In our work, we have extensively reanalyzed 935 paired-end RNA-seq experiments downloaded from "The Cancer Cell
Line Encyclopedia" repository, aiming at addressing novel putative cell-line specific gene fusion events in human malignancies. The
bioinformatics analysis has been performed by the execution of four different gene fusion detection algorithms. The results have
been further prioritized by running a bayesian classifier which makes an in silico validation. The collection of fusion events
supported by all of the predictive softwares results in a robust set of ∼ 1,700 in-silico predicted novel candidates suitable for
downstream analyses. Given the huge amount of data and information produced, computational results have been systematized in
a database named LiGeA. The database can be browsed through a dynamical and interactive web portal, further integrated with
validated data from other well known repositories. Taking advantage of the intuitive query forms, the users can easily access,
navigate, filter and select the putative gene fusions for further validations and studies. They can also find suitable experimental
models for a given fusion of interest.
Conclusions: We believe that the LiGeA resource can represent not only the first compendium of both known and putative novel
gene fusion events in the catalog of all of the human malignant cell lines, but it can also become a handy starting point for wet-lab
biologists who wish to investigate novel cancer biomarkers and specific drug targets.
Key words: Database; Human gene fusions; Malignant Cell Lines; NGS; Gene Fusion detection algorithms; Chromosomal rear-
rangements; Bioinformatics
Background
Oncogenic gene fusion events result from chromosomal rearrange-
ments which lead to the juxtaposition of two previously separated
genes. The accidental joining of DNA of two genes can generate
hybrid proteins. It can also result in the misregulation of the tran-
scription of one gene by the cis-regulatory elements (promoters or
enhancers) of another, sometimes resulting in the production of on-
coproteins that bring the cell to a neoplastic transformation 1. Not
only gene fusions can have a strong oncogenic potential 2, but they
also serve as diagnostic tools for the clinical classification of can-
cer subgroups with different prognosis and, in some cases, they may
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• A massive bioinformatics analysis conducted on Paired-End RNA-seq samples from 935 human malignant Cell Lines reveals a landscape
of known and novel in-silico predicted gene fusion events;
• LiGeA Portal represents a user-friendly database for the systematization, visualization and interrogation of the results;
• LiGeA Portal is further integrated with information from other databases and with gene-fusion priotirization analysis, in order to address
targeted experimental validations on a highly reliable set of candidate gene fusions.
provide specific drug targets 3. For instance, the presence of the
PLM-RARA fusion product is a specific hallmark of acute promye-
locytic leukemia (APL) 4 and represents the first example of gene-
fusion targeted therapy 5 that has changed the natural history of
this disease. Hence, there are several reasons why studying gene fu-
sions in cancer is very important. In recent years, Next-Generation
Sequencing (NGS) technologies have played an essential role in the
understanding of the altered genetic pathways involved in human
cancers. Nowadays, most of the studies aiming at fusion discov-
ery use NGS techniques followed by massive bioinformatics anal-
yses. The greatest challenge of these sophisticated algorithms of
prediction is the ability to discriminate between artifacts and really
occurring chromosomal rearrangements 6. Moreover, each gene fu-
sion predicting software differs in terms of sensitivity and specificity.
In the last decade, much effort has been done to catalog gene fu-
sion events, thus resulting in a wide production of databases. At
present, a dozen of published databases regarding oncogenic fusion
genes exists (see table 1 for a summary). Some of them (e.g. Fu-
sionCancer, ChiTaRS-3.1) collect in silico predictions of chimeric
genes, obtained analyzing publicly available datasets derived from
heterogeneous sources either in terms of experimental material (a
mix of Single-End and Paired-End RNA-seq data, ESTs) and in
terms of data source (patients and cell lines). Some others collect
gene fusion events with experimental evidences manually curated
from literature collection (e.g. TCGA, Mitelman, TICdb, COS-
MIC, ONGene). In this work we focused on the whole catalog of
Human malignant Cell Lines, thus obtaining a homogeneous input
NGS dataset covering several human malignancies. We exerted a
massive bioinformatics analysis on 935 paired-end RNA-seq samples
derived from 22 different tumor tissues and used a combination of
the best performing gene fusion-detecting algorithms. For ease of
understanding, we define the predicted Gene Fusion Event (pGFE)
as the entity constituted by the gene fusion couple in a specific cell
line and designate the Consensus Call-Set (CCS) as the number of
pGFEs supported by all the used algorithms. Starting from this
assumption, we obtained a total of 377,540 pGFEs, 2,521 of which
belonging to the CCS. Moreover, since not all the pGFEs can give
rise to oncogenic transformations, the use of a priotirization soft-
ware is recommended in order to distinguish between real driver
mutations from passenger ones. Therefore, a robust Bayesian classi-
fier has been used to perform an in silico validation of the results.
Since one of the main purposes of this big data analysis is encourag-
ing the reuse of our results in order to experimentally validate the
in-silico predictions, we set up a web portal collecting and system-
atizing these data, LiGeA (cancer cell LInes Gene fusion portAl). It
is possible to browse, search and freely download all the results ob-
tained and described within this article at the LiGeA repository web
page available at http://hpc-bioinformatics.cineca.it/fusion/.
To our knowledge, our resource represents the first compendium of
both known and predicted novel gene fusion events in cell lines from
22 different human tumor types.
Data Description
Methods
We have analyzed 935 paired-end RNA-seq experiments available at
the Cancer Cell Line Encyclopedia repository 15, for a total of 32
TB of input raw data. The analysis has been carried out by us-
ing four different somatic fusion gene detection algorithms: Fusion-
Catcher 16, EricScript 17, Tophat-Fusion 18 and JAFFA 19. The
choice of the algorithms was driven by the assessment from Kumar S.
et al. 20, which compared twelve methods for the fusion transcripts
detection from RNA-Seq data and identified these softwares as the
ones with the highest Positive Prediction Values. Furthermore, the
chosen softwares differ in a variety of aspects and contain several
layers of information in their output files, thus giving us the oppor-
tunity to collect and interconnect a wide set of complementary data
for each pGFE. Here is a short description of each fusion detection
tool, accompanied by the used versions and parameters.
• FusionCatcher (FC): FC is a Python based algorithm. It ex-
ecutes a first mapping run with Bowtie v.1.2.0 21 and then per-
forms the Gene fusion detection basing on three different align-
ers: Bowtie2 v.2.2.9 22, BLAT v.36 23 and STAR v.2.5.2b 24.
FC takes advantage of NCBI Viral Genomes (v. 2016-01-06) in
order to detect exogenous virus material integration into the host
genome. Moreover, the FC algorithm compares its own output
with a set of published databases, thus proving a detailed list of
truly positive and false positive pGFEs candidates. In our anal-
ysis we downloaded FC v. 0.99.5a and Ensembl genome annota-
tion v.83 and used hg38/GRCh38 as genome assembly version.
The software was executed with default parameters, requiring
111,620 CPU core hours, 125 GB of RAM and 20 CPUs to com-
plete the execution on our input dataset. Overall, FC detected
25,251 pGFEs involving 8,659 genes.
• Tophat-Fusion (TF): TF uses the Tophat-fusion-post function
in order to create a filtered list of gene fusion candidates, start-
ing from the output files obtained running Tophat with the "–
fusion-search" option 25." The following commands were run sub-
sequently:
tophat -o $Sample.output/ -p 20 –fusion-search –keep-fasta-
order –bowtie1 –no-coverage-search -r 160 –mate-std-dev 34
–max-intron-length 100000 –fusion-min-dist 100000 –fusion-
anchor-length 13 $BOWTIE_INDEX/hg38 $Sample_1.fastq
$Sample_2.fastq
cd $Sample.output/
tophat-fusion-post -p 20 –skip-blast $BOWTIE_INDEX/hg38
Tophat-2.0.12 and samtools 0.1.19 versions were used for this
study. This algorithm took about 200,000 CPU core hours, 20
CPUs and 125 GB of RAM in order to complete its runs on
the whole input dataset. TF produces several output files but
only the file named "results.txt", representing the filtered list of
predicted gene fusions, was used for subsequent analysis. The
results encompassing "Chromosome M" have been manually dis-
carded from the final results, in primis because TF and JF were
the only ones of the four algorithms reporting them, secondly be-
cause they represented bona-fide false positive outcomes. Over-
all, TF highlighted 28,146 pGFEs involving 9,492 genes.
• JAFFA (JA): JAFFA (v. 0.9) is a multi-step pipeline that
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takes raw RNA-Seq reads and outputs a set of candidate fusion
genes along with their cDNA breakpoint sequences. It relies on
trimmomatic 26, samtools 27, BLAT 23, bowtie2, bpipe 28 and
R softwares 29 as well as on gencode (v. 22) for the annota-
tion and on Mitelman database for flagging already known gene
fusions. For the purpose of this analysis, we used the "Direct"
mode pipeline which is indicated for reads of 100 bp or longer.
A total amount of 1,300,000 CPU core hours, 125 GB of RAM
and 20 CPUs were required to successfully complete the analysis.
The results encompassing "Chromosome M" have been manually
discarded from the final results. Furthermore, only pGFEs sup-
ported by at least 3 spanning reads or flagged as "known", have
been retained. Overall, after the filtering process, JA detected
53,400 pGFEs involving 12,256 genes.
• EricScript (ES): ES is developed in R, perl and bash scripts.
It uses the BWA aligner 30 to perform the mapping on the
transcriptome reference and samtools v. 0.1.19 to handle with
SAM/BAM files. Recalibration of the exon-junction reference is
performed by using BLAT. For the purposes of this project, we
used BLAT v.36, R v.3.3.1, bedtools v. 2.24, and ES version
0.5.5. The Ensembl Database v. 84 was obtained as ES supple-
mentary material 31 and built locally using BWA software with
the command:
bwa index -a bwtsw allseq.fa
A total amount of 130,900 CPU core hours, 125 GB of RAM
and 20 CPUs were required to successfully complete the analy-
sis. We further filtered out ES final results by removing all the
predictions for which the software was not able to predict an ex-
act breakpoint position because such pGFEs could not even be
experimentally validated. Secondly, as also applied to FC, TF
and JF’s results, we retained the pGFEs exhibiting at least 3
spanning reads over the gene fusion junction. Furthermore, we
filtered out all the pGFEs with EricScore value less than 0.85.
EricScore is a ranking parameter ranging from 0.5 to 1: greater
values correspond to better predictions. Interestingly, by apply-
ing these filters, we filtered out almost 2/3 of the initial predic-
tions from EricScript but, at the same time, the CCS did not
reduce substantially, thus indicating that the choice of a consen-
sus of predictions is a good strategy to remove false positives and
obtain a reliable set of gene fusion candidates to be experimen-
tally validated. Overall, after the filtering process, ES detected
293,220 pGFEs involving 14,740 genes.
Data Statistics and Validation
Overall, our extensive analysis results in a CCS of 2,521 pGFEs
(Fig. 1A) and respectively 2,828/9,258 pGFEs supported by exactly
three/two methods. As a first validation of our analysis, 661 out of
the 719 (92%) genes known to be functionally implicated in cancer
and collected under COSMIC gene census, are present in our final
dataset. As a further validation of our results, about 1/5 of our CCS
has already been published or is present in the following databases:
chimerdb3; ONGene; COSMIC; tcga; ticdb; Mitelman (Fig. 1C).
Finally, only a small subset of the pGFEs (∼10% of data) present
in the CCS have been recognized as false positive predictions, thus
supporting the idea that a combination of algorithms can be of great
utility in order to increase the sensitivity and the specificity of the
tests. It is worth mentioning that, not only our analysis confirmed
a large number of known gene fusion events, but it also highlighted
1,719 novel putative pGFEs in the CCS which could undergo further
downstream analysis (Fig. 1B). Therefore, a further step of analy-
sis was run with Oncofuse v.1.1.1 32 in order to distinguish driver
mutations (genomic abnormalities responsible for cancer) from pas-
senger ones (inert somatic mutations not implicated in carcinogene-
sis). Oncofuse is considered an in silico validation post-processing
step which prioritizes the results obtained from each of the three
algorithms. It assigns a functional prediction score to each puta-
tive fusion sequence breakpoint identified by the four softwares thus
hinting which pGFEs are worthy of being experimentally validated
and studied. Oncofuse supports multiple input formats such as the
output from TF and FC. In order to run it also on the outputs from
ES and JF, a short pre-processing step was executed on these data.
As suggested on Oncofuse manual, the accepted default input for-
mat is a tab-delimited file with lines containing 5’ and 3’ breakpoint
positions. Therefore, these columns were extracted from ES and JF
output files and redirected into Oncofuse accepted input format. On-
cofuse was run with default parameters using hg38 as the reference
genome.
Availability of supporting data and materials
The datasets obtained and described within this article are
freely downloadable at the LiGeA repository available at
http://hpc-bioinformatics.cineca.it/fusion/downloads. More-
over, archival copies of processed files and the source code are avail-
able via the GigaScience database, GigaDB 33.
Database Description
LiGeA is a database server based on graph-db technology (Neo4j).
The portal stores all of the results obtained from each fusion gene
predicting algorithm and the prioritization analysis outcome. Any-
way, this database contains not only a mere collection of in silico
predictions. Indeed, it has been integrated with other useful exter-
nal resources in order to offer a carefully-curated web compendium.
Here is a short list of the added features:
• Whenever the gene fusion couple has already been experimen-
tally validated and published, an extra column with COSMIC
icon is added to the results. By clicking on it, the user will
be redirected to an external link containing a manually-curated
catalog of 212 literature-derived somatic mutations in cancer 34;
• Cancer Gene Census is a manually curated catalog of 719 genes
for which mutations have been causally implicated in oncogen-
esis 35. Whenever one of the two genes involved in the pGFE
has been already described to be implicated in cancer, the gene
is tagged with an icon. By clicking on it, an external link to
the Cancer Gene Census is provided showing a table of genes
included within this category 36.
• A legend based on a colorful signature has been added to tag the
FC predictions as ’validated truly positive couples’ (green cir-
cle), ’validated false positive couples’ (red circle), ’false positive
couples with medium probability’ (orange circle) and ’ambiguous
signature’ because tagged with both positive and negative values
(grey circle) ;
• A functional prediction score obtained by extensively running the
Oncofuse software, is reported as additional tag to the outputs
from each algorithm.
LiGeA portal is divided into several sections which allow a user-
friendly navigation.
• Home: In the homepage, the user is provided with a quick
overview of the database. A global summary table reports a nu-
meric recapitulation (e.g. the number of genes/transcripts/exons
collected into the portal; the number of predicted proteins and
so on). Moreover, a histogram shows an abstract of the top 50
involved cell lines. By moving the cursor on the bars, a pop-up
opens showing the cell line name and the corresponding num-
ber of the unique fusion events predicted by all the algorithms.
Information about the algorithm predictions hosted into the por-
tal are supplied with an interactive Venn Diagram linked to a
dynamical table. Upon user selection of the algorithm/s of in-
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Figure 1. a) Venn diagram showing the intersection of the pGFEs identified by the four algorithms. b) Distribution of pGFEs in the Consensus Call-set:
43% (purple) of the CCS has not been previously described in any other database or scientific publication; 10% (red) and 20% (green) of the CCS
have been reported in databases from healthy/tumoral samples thus representing the false/true positive subset of our analysis; 1% of the CCS (orange)
reports tags which classify the pGFE as a false positive couple with medium probability; 25% (grey) of the results represent novel pGFEs tagged with
values which classify them as both false and true positives. c) Venn diagram showing the intersection between the LiGeA CCS and other databases.
Figure 2. An overview of LiGeA portal. a) A ’Search by Cell line’ example and the corresponding output; b) An overview of the input dataset; c) A
circos diagram showing the graphical outcome of a ’Query by cell line’ and the corresponding related table; d) An extract from the ’Download’ web page.
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terest, both the diagram and the table refresh thus showing the
resulting number of intersections.
• Search: This utility allows several searching options to browse
and mine genomic-fusion events stored in LiGeA portal (see table
2 for an overview). All the resulting outputs are sorted by the
number of algorithms supporting the fusion events, thus show-
ing on the top of the table the most robust set of results. As
additional feature, when specifying the features of interest, it is
also possible to choose the minimum number of predicting algo-
rithms. Search results are presented in the form of a paginated
table containing those fusion events which satisfy the query pa-
rameters and data can also be downloaded in tabular format.
Furthermore, by clicking on a given fusion ID, it is possible to
access the event-specific page in which relevant information is
presented in greater detail (e.g., involved cell line, disease, genes
as well as links to external databases and resources). Two out
of nine of the query forms (’search by fusion information’ and
’search by virus’) are specific annotations derived FC algorithm.
Here is a short description of the provided searching utilities.
• ’Search by Disease’: In this section, all the cell lines derived
from the same disease have been grouped together. In this way,
it is possible to navigate the gene fusions putatively causing spe-
cific malignancies. The number of the cell lines constituting the
queried subset is shown besides the pathology name.
• ’Search by Cell Line’: This module allows to navigate the
database by indicating a specific cell line name. It is possible
to tune the results by showing only the novel predictions not yet
described in any other database or publication (Fig.2A).
• ’Search by Chromosome’: This query can be performed by insert-
ing one or two chromosomes involved in the fusion event. The
cell line name can be either indicated or not.
• ’Search by Gene’: the user can select up to two gene names (Gene
Symbol or ENSEMBL ID) and the ’cell line’ form can be either
selected or not. The genes reported in the query form are black
if they are involved in pGFE and gray if they are not.
• ’Search by Transcript’: Since the same gene can give rise to
different transcripts, it could be reasonable to query which of
the transcripts produced by a specific gene are affected by a
fusion event. This kind of query can be satisfied by inserting the
Ensembl Transcript (ENST) IDs in the specific form.
• ’Search by Exon’: Some of the queries allow to go much more
into molecular detail. This search can be done by inserting one or
two exon IDs involved in the fusion event. The cell line name can
be either indicated or not. In this way it is possible to highlight
the specific exons which turn out to be fused in the final result.
• ’Search by Fusion information’: The pGFEs may have different
predicted effects. Indeed, depending on the location of the chro-
mosomal break points, the resulting protein may be in-frame,
out-of frame, truncated and so on. Since the selectable values
present in the fusion information form are specific of FC algo-
rithm, the result of this query returns a table without ES,JA
and TF data. We suggest to view the FC manual in order to
obtain a full description of all of the tags.
• ’Search by Algorithm’: this type of query is suitable for users who
wish to navigate the outputs from specific softwares, choosing
them individually or in combination. Indeed, it is known that
some kind of fusions, such as those involving immunoglobulins,
can be detected by specific softwares 37.
• ’Search by Viruses’: Another useful information retrievable from
the database regards virus sequence integration into the host
genome. This search utility is virus-centered since it is possible
to indicate or not the host cell line name. It is possible to select
the virus name of interest (whether using GI ID or NC ID). Fur-
thermore, a clickable link redirecting to the virus genome is also
shown on the right of the table.
• Statistics: this section allows a visual inspection of the results.
The four sub-menus are organized as follows:
– ’Cell Line Statistics’: by choosing the Cell Line of interest,
the resulting circular diagram shows all the chromosome cou-
ples involved in GFE predicted by at least two algorithms.
The table on the right summarizes the resulting couples of
the genes and chromosomes (Fig. 2C).
– ’Chromosome Statistics’: this page reports a dynamical pie-
chart showing the number of fusion events per human chromo-
some; by clicking on each slice of the pie, the related table au-
tomatically updates showing a chromosome summary statis-
tics. Furthermore, information about the number of inter-
and intra-chromosomal rearrangements detected by each al-
gorithm is also reported.
– ’Disease Statistics’: The ’Fusion Statistics’ pie-chart was pro-
duced by grouping together the cell lines derived from the
same human pathology thus showing the total number of fu-
sion events normalized by the number of cell lines composing
a specific disease. The ’Virus statistics panel’ shows the fre-
quency of exogenous virus integration per human malignancy.
– ’Gene Statistics’: A word cloud diagram showing the most
recurring pGFEs supported by three methods.
– ’Database Statistics’: This sub-section is composed by four
panels, the first regarding data in the CCS (Fig. 1B), the
others relating only to FC and JA results. In this page it is
possible to get information about the number of pGFEs found
in known databases (visualized as interactive Venn diagrams
and tabular fashion) and the distribution of predicted effects
(histogram view).
• Dataset: This page is a description of the input dataset used
for the analysis. Among the above 1000 samples available at
the Broad institute portal 15, we downloaded 935 PE RNA-seq
samples in fastq format. The SE samples have been discarded
since the used softwares required it. The histogram in this sec-
tion shows the number of the different cell lines derived from the
same diseases (Fig. 2B). Furthermore, starting from this section,
it is possible to access to web pages resuming cell-line specific de-
tails (e.g. COSMIC ID, drug resistance, human disease among
others) .
• Downloads: From this panel it is possible to download all the
processed data described within this article (Fig. 2D). Some of
the files (’Summary information’ and ’Viruses information’) are
specific products of FusionCatcher algorithm.
Availability and Requirements
• Project name: LiGeA: a comprehensive database of human
gene fusion events
• RRID: SCR_015940
• Project home page: http://hpc-bioinformatics.cineca.it/fusion
(GitHub project: https://github.com/tflati/fusion)
• Operating system(s): Any
• Programming language: Python, JavaScript+HTML+CSS
• Other requirements: Django 1.10.5, Python 2.7.12, AngularJS
1.5.11
• License: GNU GPLv3
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Table 2. Example of possible queries on LiGeA portal
Search by Question Query
Disease ’what are the gene
fusion events
present in stomach
adenocarcinoma
cell lines?’
Select ’stomach
adenocarcinoma’
under ’disease’
menu
Cell Line ’what are the novel
pGFEs affecting
RH30(Sarcoma)
cell line?’
Select ’RH30’
under the cell line
menu and check
the box ’show only
novel results’
Chromosome ’what are the most
suitable fusion
partners for
chromosome 8?’
Select ’Chr8’
either under the ’5’
Chromosome’ or
under the ’3’
Chromosome’ tab
and leave blank
the other forms
Gene ’how many human
cell lines show the
PML-RARA
fusion event?’
Select ’PML’
under the ’5’ gene
menu’; Select
’RARA’ from the
’3’ gene menu’;
leave blank the
’Cell Line’ query
form;
Fusion information ’what are all the
in-frame pGFEs in
Jurkat cell line?’
select ’Jurkat’
under ’Cell line’
menu; Select
’in-frame’ under
’predicted effect
menu
Fusion information ’what are the
known GFEs
predicted to be
in-frame in Jurkat
cell line?’
Select ’Jurkat’
under ’Cell line’
menu; Select
’in-frame’ under
’predicted effect
menu; select
’known’ under
’Fusion description’
menu
Algorithm ’show only those
GFEs supported
by FC and TF in
RH30 cell line’
Select ’RH30’
under ’Cell Line’
query form and
check the boxes
relative to FC and
TF
Viruses ’which cell lines
are most affected
by Hepatitis C
virus genome
integration?’
Select ’Hepatitis C
virus’ under ’Virus’
query form and let
blank the ’Cell
line’ query form
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Table 1. State of the art of databases reporting gene fusions
Database Name Short Description
Tumor Fusion Gene Data Portal 7 A collection of fusion genes in the Tumor Cancer Genome Atlas (TCGA) samples.
TICdb 8 A collection of 1,374 fusion sequences extracted either from public databases or from published
papers (last update: 2013).
chimerDB3.0 9 A catalog of fusion genes encompassing analysis of TCGA data and manual curations from
literature.
COSMIC Cell Lines 10 Gene fusions are manually curated from peer reviewed publications. Currently COSMIC includes
information on fusions involved in solid tumors but not yet leukemias and lymphomas.
Mitelman 1 Reports hundreds of gene fusions associated with clinical reports but does not contain sequence
data.
ChiTaRs-3.1 11 A collection of 34,922 chimeric transcripts identified by Expressed Sequence Tags (ESTs) and
mRNAs from the GenBank, ChimerDB, dbCRID, TICdb and the Mitelman collection of cancer
fusions for several organisms.
FusionCancer 12 591 samples, both single-end and paired-end RNA-seq, published on SRA database 13 between
2008 and 2014 covering 15 kinds of human cancers .
ONGene 14 Literature-derived database of oncogenes.
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